The Cannabis Compassion Program

We know what a financial hardship living with chronic illness creates. This is why we have created the Cannabis Compassion Program – to donate at least 1% of our sales to economically distressed patients, free of charge.

To qualify, patients must complete an application and submit financial documents demonstrating need.  Details about what documents are accepted can be found in the application FAQ section.

Each round of awards will last 6 months and run from July 1 to December 31, and from January 1 to June 30 of every year.  Applications for the round beginning in July will be accepted during the month of May, and for the January round applications will be accepted during the month of November.  Awards will not be determined on a first come first served basis – applications submitted on May 1 will not receive any preference over one received May 31.  However, preference in subsequent rounds will be given to applicants who have previously applied but were not chosen.

Awards will be determined at random from among all eligible applicants.  We will then work with each awardee to develop a schedule and product plan that is tailored to that individual’s needs, within the resources we have available.

All patient information will be kept strictly confidential in accordance with federal standards for collecting, processing, and storing personal and medical information; and all application material will be destroyed at the end of the award cycle.

During the application acceptance periods of May and November, applications can be found on the Forms Page or downloaded directly here.  Completed applications may only be submitted in person at the dispensary.  Any questions concerning the program should be by email.

We’d like to thank our colleagues at the Berkeley Patients Group for inspiring us to create this program and we owe a deep thanks to the following Illinois cultivator partners, whose contributions to this program has enabled us to expand this program’s reach to many more patients than would otherwise have been possible.

Ataraxia

Bedford Grow

Cresco Labs

Green Thumb Industries

Justice Grown

Progressive Treatment Solutions

Revolution Cannabis

Wellness Group Pharms

Qualifying Conditions

AIDS
Agitation Of Alzheimer’s Disease
ALS
Arnold-Chiari Malformation And Syringomelia
Cachexia/Wasting Syndrome
Cancer
Causalgia
Chronic Inflammatory Demyelinating Polyneuropathy
Crohn’s Disease
CRPS (Complex Regional Pain Syndrome Type II)
Dystonia
Fibromyalgia (Severe)
Fibrous Dysplasia
Glaucoma
Hepatitis C
Human Immunodeficiency Virus (HIV)
Hydrocephalus
Interstitial Cystitis
Lupus
Multiple Sclerosis
Muscular Dystrophy
Myasthenia Gravis
Myoclonus
Nail-Patella Syndrome
Neurofibromatosis
Parkinson’s Disease
Post-Concussion Syndrome
Post Traumatic Stress Disorder (PTSD)
RSD (Complex Regional Pain Syndromes Type I)
Residual Limb Pain
Rheumatoid Arthritis (RA)
Seizures, Including Those Characteristic Of Epilepsy
Sjogren’s Syndrome
Spinal Cord Disease
Spinal Cord Injury
Spinocerebellar Ataxia (SCA)
Terminal Illness
Tourette’s Syndrome
Traumatic Brain Injury (TBI)